Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6130761rdf:typepubmed:Citationlld:pubmed
pubmed-article:6130761lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:6130761lifeskim:mentionsumls-concept:C0227525lld:lifeskim
pubmed-article:6130761lifeskim:mentionsumls-concept:C0023820lld:lifeskim
pubmed-article:6130761lifeskim:mentionsumls-concept:C0006772lld:lifeskim
pubmed-article:6130761lifeskim:mentionsumls-concept:C1709694lld:lifeskim
pubmed-article:6130761lifeskim:mentionsumls-concept:C1314939lld:lifeskim
pubmed-article:6130761pubmed:issue2lld:pubmed
pubmed-article:6130761pubmed:dateCreated1983-3-11lld:pubmed
pubmed-article:6130761pubmed:abstractText1. Modified lipoproteins have been implicated to play a significant role in the pathogenesis of atherosclerosis. In view of this we studied the fate and mechanism of uptake in vivo of acetylated human low-density lipoprotein (acetyl-LDL). Injected intravenously into rats, acetyl-LDL is rapidly cleared from the blood. At 10min after intravenous injection, 83% of the injected dose is recovered in liver. Separation of the liver into a parenchymal and non-parenchymal cell fraction indicates that the non-parenchymal cells contain a 30-50-fold higher amount of radioactivity per mg of cell protein than the parenchymal cells. 2. When incubated in vitro, freshly isolated non-parenchymal cells show a cell-association of acetyl-LDL that is 13-fold higher per mg of cell protein than with parenchymal cells, and the degradation of acetyl-LDL is 50-fold higher. The degradation of acetyl-LDL by both cell types is blocked by chloroquine (10-50mum) and NH(4)Cl (10mm), indicating that it occurs in the lysosomes. Competition experiments indicate the presence of a specific acetyl-LDL receptor and degradation pathway, which is different from that for native LDL. 3. Degradation of acetyl-LDL by non-parenchymal cells is completely blocked by trifluoperazine, penfluridol and chlorpromazine with a relative effectivity that corresponds to their effectivity as calmodulin inhibitors. The high-affinity degradation of human LDL is also blocked by trifluoperazine (100mum). The inhibition of the processing of acetyl-LDL occurs at a site after the binding-internalization process and before intralysosomal degradation. It is suggested that calmodulin, or a target with a similar sensitivity to calmodulin inhibitors, is involved in the transport of the endocytosed acetyl-LDL to or into the lysosomes. 4. It is concluded that the liver, and in particular non-parenchymal liver cells, are in vivo the major site for acetyl-LDL uptake. This efficient uptake and degradation mechanism for acetyl-LDL in the liver might form in vivo the major protection system against the potential pathogenic action of modified lipoproteins.lld:pubmed
pubmed-article:6130761pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6130761pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6130761pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6130761pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6130761pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6130761pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6130761pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6130761pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6130761pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6130761pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6130761pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6130761pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6130761pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6130761pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6130761pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6130761pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6130761pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6130761pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6130761pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6130761pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6130761pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6130761pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6130761pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6130761pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6130761pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6130761pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6130761pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6130761pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6130761pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6130761pubmed:languageenglld:pubmed
pubmed-article:6130761pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6130761pubmed:citationSubsetIMlld:pubmed
pubmed-article:6130761pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6130761pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6130761pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6130761pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6130761pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6130761pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6130761pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6130761pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6130761pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6130761pubmed:statusMEDLINElld:pubmed
pubmed-article:6130761pubmed:monthNovlld:pubmed
pubmed-article:6130761pubmed:issn0264-6021lld:pubmed
pubmed-article:6130761pubmed:authorpubmed-author:Van BerkelT...lld:pubmed
pubmed-article:6130761pubmed:authorpubmed-author:KruijtJ KJKlld:pubmed
pubmed-article:6130761pubmed:authorpubmed-author:HarkeyJJlld:pubmed
pubmed-article:6130761pubmed:authorpubmed-author:NagelkerkeJ...lld:pubmed
pubmed-article:6130761pubmed:issnTypePrintlld:pubmed
pubmed-article:6130761pubmed:day15lld:pubmed
pubmed-article:6130761pubmed:volume208lld:pubmed
pubmed-article:6130761pubmed:ownerNLMlld:pubmed
pubmed-article:6130761pubmed:authorsCompleteYlld:pubmed
pubmed-article:6130761pubmed:pagination493-503lld:pubmed
pubmed-article:6130761pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:6130761pubmed:meshHeadingpubmed-meshheading:6130761-...lld:pubmed
pubmed-article:6130761pubmed:meshHeadingpubmed-meshheading:6130761-...lld:pubmed
pubmed-article:6130761pubmed:meshHeadingpubmed-meshheading:6130761-...lld:pubmed
pubmed-article:6130761pubmed:meshHeadingpubmed-meshheading:6130761-...lld:pubmed
pubmed-article:6130761pubmed:meshHeadingpubmed-meshheading:6130761-...lld:pubmed
pubmed-article:6130761pubmed:meshHeadingpubmed-meshheading:6130761-...lld:pubmed
pubmed-article:6130761pubmed:meshHeadingpubmed-meshheading:6130761-...lld:pubmed
pubmed-article:6130761pubmed:meshHeadingpubmed-meshheading:6130761-...lld:pubmed
pubmed-article:6130761pubmed:meshHeadingpubmed-meshheading:6130761-...lld:pubmed
pubmed-article:6130761pubmed:meshHeadingpubmed-meshheading:6130761-...lld:pubmed
pubmed-article:6130761pubmed:meshHeadingpubmed-meshheading:6130761-...lld:pubmed
pubmed-article:6130761pubmed:meshHeadingpubmed-meshheading:6130761-...lld:pubmed
pubmed-article:6130761pubmed:meshHeadingpubmed-meshheading:6130761-...lld:pubmed
pubmed-article:6130761pubmed:year1982lld:pubmed
pubmed-article:6130761pubmed:articleTitleProcessing of acetylated human low-density lipoprotein by parenchymal and non-parenchymal liver cells. Involvement of calmodulin?lld:pubmed
pubmed-article:6130761pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6130761pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:6130761pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6130761lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6130761lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6130761lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6130761lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6130761lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6130761lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6130761lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6130761lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6130761lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6130761lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6130761lld:pubmed